Document Detail

Application of proteomics to prenatal screening and diagnosis for aneuploidies.
MedLine Citation:
PMID:  20961197     Owner:  NLM     Status:  In-Data-Review    
Abstract Current screening for fetal aneuploidies relies on biochemical and ultrasound measurements, and the sensitivity and specificity needs to be improved to reduce the number of pregnant women subjected to invasive diagnostic procedures, such as amniocentesis. Proteomic technologies enable new strategies for discovering biomarkers from complex biological fluids in a high-throughput and sensitive manner. Since mass spectrometry-based techniques allow for both qualitative and quantitative analysis of a given proteome, they have been widely used to resolve and compare the proteome of maternal plasma, serum, urine, cervical-vaginal fluid, and amniotic fluid. Comparisons of proteomes of normal fluids with those from aneuploidy pregnancies have revealed a host of candidate markers that still need to be verified. In parallel with proteomics, there is interest in other emerging techniques, such as RNA-SNP analysis or quantitation of fetal DNA by shotgun sequencing. Although these genomic techniques hold much promise, discovery of additional markers via quantitative proteomic comparisons could drastically improve current conventional screening at reasonable cost. Proteomics-based biomarker discovery is applicable to detection of not just aneuploidies, but also other pregnancy-related diseases.
Chan-Kyung J Cho; Eleftherios P Diamandis
Related Documents :
6638717 - Pregnancy in patients with cystic fibrosis.
23014257 - Hba1c in pregnancy.
17851807 - Fetal gender screening by ultrasound at 11 to 13(+6) weeks.
20961197 - Application of proteomics to prenatal screening and diagnosis for aneuploidies.
8243677 - The association of antithyroid antibodies in euthyroid nonpregnant women with recurrent...
12393967 - Anticytomegalovirus igg avidity in pregnancy: a 2-year prospective study.
Publication Detail:
Type:  Journal Article     Date:  2010-10-20
Journal Detail:
Title:  Clinical chemistry and laboratory medicine : CCLM / FESCC     Volume:  49     ISSN:  1434-6621     ISO Abbreviation:  Clin. Chem. Lab. Med.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-01-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9806306     Medline TA:  Clin Chem Lab Med     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  33-41     Citation Subset:  IM    
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Non-invasive assessment of liver fibrosis: it is time for laboratory medicine.
Next Document:  IFCC Scientific Division.